Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
| Trades 6 | Longs Won 3/6 50% | Profit Factor 37.49 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $8,220.29 |
| Average Win $14,094.1 | Best Trade (Mar 14) $17,863.85 | Sharpe Ratio -45.88 |
| Average Loss -$375.98 | Worst Trade (Jul 31) -$1,127.93 | Z-Score -2.28 (100%) |
| Commissions $0 | Avg. Trade Length 1m 2w 6d | Expectancy $6,859.06 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.2% | 5.34% |
| Consecutive Losing Trades | 375 | 338 | 300 | 263 | 225 | 188 | 150 | 113 | 75 | 38 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
MDGL Madrigal Pharmaceuticals, Inc. | 258.11 | $142,282.31 | $141,154.38 | - | -$1,127.93 | -0.79% | 0.0 |